Who are Cymabay's investors?

Cymabay's investors include Avoro Capital Advisors, Bay City Capital, Foresite Capital, VantagePoint Capital Partners.

How much funding has Cymabay raised?

Cymabay has disclosed $325K raised across 1 round.

Where is Cymabay headquartered?

Cymabay is headquartered in Newark, US.

Cymabay

Newark, US · 4 known investors

Gilead Sciences is a biopharmaceutical company that develops medicines across virology, oncology, and inflammation, with more than 25 medicines offered globally and a clinical pipeline spanning these three therapeutic areas. The content served corresponds to Gilead rather than CymaBay.

Biotech Healthtech

Founders & leadership

Harold Van Wart, Ph. D.Executive

Pol BoudesExecutive

Charles A. McWherter, Ph. D.Executive

Sujal ShahExecutive

Board

Carl Goldfischer, M.D.Board director

Kurt von EmsterBoard director

Hari Kumar, Ph.D.Board director

Louis G. Lange, M.D., Ph.D.Board director

Robert J. WillsBoard director

Investors · 4

Avoro Capital AdvisorsNew York

Bay City CapitalSan Rafael · $5M – $10M

Foresite CapitalWest Hollywood

VantagePoint Capital PartnersSilicon Valley · $2M – $100M

Reported raises · per SEC filings

Form D private placements

$325K disclosed across 1 round · 2015

▶$325KraisedAug 2015 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Harold Van Wart, Ph. D.Executive Officer, Director
Carl Goldfischer, M.D.Director
Pol BoudesExecutive Officer
Kurt von EmsterDirector
Hari Kumar, Ph.D.Director
Charles A. McWherter, Ph. D.Executive Officer
Louis G. Lange, M.D., Ph.D.Director
Robert J. WillsDirector
Sujal ShahExecutive Officer

Offering amount: $325K
Amount sold: $325K
First sale: Aug 2015
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Cymabay do?: Gilead Sciences is a biopharmaceutical company that develops medicines across virology, oncology, and inflammation, with more than 25 medicines offered globally and a clinical pipeline spanning these three therapeutic areas. The content served corresponds to Gilead rather than CymaBay.
Who are Cymabay's investors?: Cymabay's investors include Avoro Capital Advisors, Bay City Capital, Foresite Capital, VantagePoint Capital Partners.
How much funding has Cymabay raised?: Cymabay has disclosed $325K raised across 1 round.
Where is Cymabay headquartered?: Cymabay is headquartered in Newark, US.